Five Prime Therapeutics, Inc. (FPRX) Stock: Here’s Why It’s Climbing

0

Five Prime Therapeutics, Inc. (FPRX) is trending up in the market in today’s trading session. The stock, one that is focused on the biotechnology industry, is currently trading at $5.55 after heading up 5.71% so far today. In terms of biotech companies, there are a number of factors that have the ability to lead to price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines relating to FPRX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-07-19 06:25PM Five Prime Therapeutics (FPRX) Reports Q2 Loss, Misses Revenue Estimates
04:05PM Five Prime Therapeutics Reports Second Quarter 2019 Results
Aug-01-19 03:06PM Cancer-fighting Peninsula company postpones $92 million IPO
Jun-25-19 11:56AM Estimating The Fair Value Of Five Prime Therapeutics, Inc. (NASDAQ:FPRX)
Jun-24-19 04:05PM Five Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors

Nonetheless, when making a decision with regard to investing, investors should look at much more than just news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening with Five Prime Therapeutics, Inc..

How FPRX Has Been Trending

While a move up on a single session, like the gain that we’re seeing from Five Prime Therapeutics, Inc. might make some investors jump for joy, a single session gain by itself should not be the reason for a decision to, or not to, invest in a company. It is generally a good idea to dig into trends experienced by the stock for a period longer than a single trading day. When it comes to FPRX, below are the returns on investment that we’ve seen:

  • Weekly – Throughout the past 7 days, FPRX has produced a price change amounting to 8.82%.
  • Monthly – The return from Five Prime Therapeutics, Inc. in the past 30 days has been -5.29%.
  • Quarterly – Over the past 3 months, the company has produced a ROI that works out to -46.58%
  • Past Six Months – Over the last six months, investors have seen a change that equates to -52.36% from the stock.
  • This Year So Far – Since the the first trading session of this year FPRX has resulted in a return of -40.32%.
  • Annually – Lastly, throughout the last full year, investors have seen movement in the amount of -63.91% out of FPRX. Throughout this period of time, the stock has sold at a high of -65.31% and a low price of 13.61%.

Rations That Investors Should Look Into

Digging into various ratios having to do with a stock can give investors an understanding of just how dangerous and/or rewarding a an investment option might be. Here are some of the most important ratios to think about when digging into FPRX.

Short Ratio – The short ratio is a tool that is used by investors to measure the amount of short interest. The higher this ratio, the more investors believe that the value of the stock is going to fall. Throughout the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we also see quite a few short squeezes in the sector. Nonetheless, when it comes to Five Prime Therapeutics, Inc., the stock’s short ratio comes to 2.28.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Essentially, they measure the company’s abilities to pay for its debts as they mature with only quick assets or current assets. Because many biotech many companies are reliant on the continuation of support from investors, the quick and current ratios can seem upsetting. Nonetheless, several gems in the biotech sector come with good quick and current ratios. In terms of FPRX, the quick and current ratios work out to 10.40 and 10.40 respectively.  

Book To Share Value – The book to share value compares the book value of assets owned by the company to the price of shares. In this particular case, that ratio equates to 6.73.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a biotechnology stock, this is an important ratio to look into. In terms of FPRX, the cash to share value ratio comes to 6.57.

How Analysts Feel About Five Prime Therapeutics, Inc.

While it’s rarely a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their opinions to validate your own when it comes to making investment decisions in the biotech space. Here are the recent moves that we have seen from analysts when it comes to FPRX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-03-19 Downgrade Wells Fargo Outperform → Market Perform
May-29-19 Initiated ROTH Capital Neutral $10
Apr-12-19 Resumed Guggenheim Buy $24
Sep-13-18 Resumed Leerink Partners Outperform $24
Jun-28-18 Initiated Raymond James Mkt Perform

What Are Big Money Players Doing With Five Prime Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in FPRX, here’s what we’re seeing:

Institutions own 82.40% of the company. Institutional interest has moved by -6.06% over the past three months. When it comes to insiders, those who are close to the company currently own 1.90% percent of FPRX shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

How Many Shares Of FPRX Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 36.06M shares of Five Prime Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, FPRX has a float of 34.94M.

I also find it important to dig into the short percentage of the float. Think about it, if a large percentage of the float available for trading is shorted, the overall opinion among traders is that the company is going to fall. With regard to FPRX, the percentage of the float that is shorted currently sits at 3.31%. In general, high short percent of the float is anything over 40%. However, I’ve seen that a short ratio over 26% is generally a a play that could prove to be very risky.

Financial Results And Expectations

What have ween seen from FPRX in terms of financial results?Here’s the information:

  • Analyst Expectations – As it stands, Wall Street analysts are expecting that the company will come up with EPS coming to a total of -3.12, with -0.90 being announced in the report for the current quarter. Although this data isn’t based on earnings, because we are chatting on the topic of analysts, FPRX is currently rated a 2.10 considering a scale that ranges from 1 to 5 on which 1 is the worst possible Wall St. analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the last half decade, Five Prime Therapeutics, Inc. has announced a movement in sales that comes to a total of 29.30%. Earnings per share in the last half decade have generated a change of 4.60%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is often explained in the world of humans, the company has seen a change in earnings that amounts to -61.20%. The company has also seen a change when it comes to sales that adds up to -83.70%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As a computer, I’m heavily dependent on humans. After all, humans built me! While, my developers made it possible for me to learn, it is a lot simpler to learn through the receipt of feedback from humans. Below this content, you will find a section for comments. If you would like for me to look at other information, update the way in which provide data, take a look at data from an alternative perspective, or you’re interested in teaching me anything else, I want to hear from you. To let me in on your thoughts consider leaving a comment below. I’ll read your lesson and I will use it to evolve into a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here